MATERIALS AND METHODS Antibiotics. T-1220, shown in Fig. 1 , was synthesized in the Research Laboratory of Toyama Chemical Co., Ltd. The crystalline form used in these studies was prepared by freeze-drying an aqueous solution of T-1220 and was more than 98% pure. Other antibiotics used for comparison were commercial products.
Test strains. Strains stocked in this laboratory were used as standards. Stock cultures of the Reference Laboratory ofDrug-Resistant Bacteria, Gunma University, were originally isolated from clinical materials.
Media. Media used in this experiment were as follows. Heart infusion (HI) agar, brain heart infusion agar, HI broth, and brain heart infusion broth were products of Eiken Chemical Co., Ltd. Other media used were peptone water and medium-B. Peptone water consisted of 10 g of polypeptone, 5 g of NaCl, and 1,000 ml of distilled water. Medium-B consisted of 2 g of yeast extract, 10 g of polypeptone, 7 g of Na2HPO4 12H20, 2 g of KH2PO4, 1.2 g of glucose, and 0.4 g of MgSO4 7H20 in 1,000 ml of distilled water.
In vitro antibacterial activity. Minimal inhibitory concentrations (MICs) of antibiotics were determined by a standard twofold serial dilution method, using HI agar. Overnight cultures in peptone broth were used for precultures of tested strains. Brain heart infusion agar was used for determination of the MIC against Streptococcus pyogenes. KNO3 was added to peptone broth in a final concentration of 0.4% to yield a homogeneous culture of the P. aeruginosa strain. MICs were determined after overnight incubation at 37°C, with an inoculum equivalent to a 10-2 dilution of an 18-h culture in peptone broth (about 108 cells/ml). Each inoculum was seeded onto the agar plates by use of an inoculum-replicating apparatus and transferred by a 0.005-ml calibrated loop.
Effects of human serum on the antibacterial activity were examined by using a twofold dilution method in HI broth. (3, 18) , and W3630 Rte16+ (15) and P. aeruginosa ML4259 Rms139+, ML4259 Rms149+, and ML4259 Rms242+ (13) were used as the standard strains capable of producing the known types of PCase. P. aeruginosa GN918 and E. coli GN5482 were used as the standard strains capable ofproducing cephalosporinase (16) .
In vivo antibacterial activity. Fifteen ICR strain male mice, weighing 18 to 20 g each, were used for each dose level. Mice were challenged intraperitoneally with sufficient microorganisms to kill all nontreated mice within 72 h. Microorganisms grown on an HI agar plate were suspended in physiological saline solution. Klebsiella pneumoniae GN6445 and P. aeruginosa NC-5 were suspended in physiological saline containing 1 and 5% mucin (Wako Chemical Co., Tokyo; hog gastric mucin, LP-K type), respectively. Mice infected with E. coli ML4707 were treated 1 h after infection. Mice infected with K. pneumoniae GN6445 and P. aeruginosa NC-5 were treated, respectively, at 1 and 4 h and 1, 4, and 8 h after infection. The total number of surviving mice was recorded, usually 1 week after infection, and the amount of a single dose (milligrams per kilogram) that gave protection to 50% of the infected mice was estimated by means of a log-probit plot (6) .
RESULTS AND DISCUSSION Antibacterial spectrum. The spectrum of antibacterial activity of T-1220 against gram-positive and gram-negative bacteria is shown in Table 1 . T-1220 was active against gram-positive organisms susceptible to CB-PC and AB-PC. T-1220 was slightly more active than CB-PC but less active than AB-PC against grampositive organisms that do not produce PCase. T-1220 was also active against gram-negative organisms, and the MICs of T-1220 were less than those of CB-PC and AB-PC against gramnegative organisms susceptible to both drugs. It was characteristic that T-1220 was highly active against gram-negative organisms, i.e., Serratia marcescens, K. pneumoniae, Proteus species, Enterobacter cloacae, and P. aeruginosa, which were resistant to either or both drugs. Antibacterial activity. The antibacterial activity of T-1220 against gram-positive and gram-negative organisms was compared with that of AB-PC and CB-PC by cumulative percentages of strains inhibited by various concentrations of the drugs. The representative results at 3.13 and 12.5 ,g/ml are shown in Table  2 . The percentage of isolates of gram-negative bacteria inhibited by T-1220 was somewhat larger than that of CB-PC and AB-PC.
Cumulative percentages of 200 E. coli strains inhibited by T-1220, AB-PC, and CB-PC are illustrated in Fig. 2 . The concentration of T-1220 required to inhibit the growth of 50% ofthe total number of tested E. coli strains (MIC.) was 1.56 to 3.13 ug/ml; MIC50 values of AB-PC and CB-PC were 6.25 ,tg/ml, respectively.
The MIC50 of T-1220 against K. pneumoniae strains was 3.13 to 6.25 ug/ml; MIC50 values of AB-PC and CB-PC were 50 to 100 ,ug/ml, respectively. Therefore, T-1220 was approximately 10 times more active than AB-PC and CB-PC (Fig. 3) .
Large differences were seen in the MIC distributions of T-1220 and CB-PC against 300 P. aeruginosa strains; the peaks ofT-1220 and CB-PC were located at 6.25 and 50.0 ,ug/ml, respectively. The M1C. values of T-1220 and CB-PC against P. aeruginosa strains were 3.13 and 50.0 ug/ml, respectively; T-1220 was approxi- mately 10 times more active than CB-PC (Fig. 4) . Effects of different culture media and pH values on the MICs of T-1220 were not great. The addition of human serum at 10 and 40% did not alter the inhibitory effect of T-1220 against E. coli NIHJ, Staphylococcus aureus FDA 209P, or P. aeruginosa NCTC 10490 (Table 3) .
Bactericidal activity. Correlation of MICs and minimum bactericidal concentrations of T-1220 is shown in Table 4 . The minimum bactericidal concentrations of T-1220 against most of the tested strains seemed to be the same or only twofold higher than the MICs. However, the minimum bactericidal concentrations of T-1220 against PCase-producing strains, i.e., K. pneumoniae GN5559, Proteus vulgaris GN1543, P. vulgaris IID874, and P. aeruginosa GN6727, were four-or eightfold higher than the MICs. Susceptibility to PCase. The R-mediated PCases were classified into four types (3, 13, 17, 18) , and a type IV PCase capable of specifically hydrolyzing CB-PC was demonstrated from P. aeruginosa strains carrying R plasmids (9, 13) . The relative rate of hydrolysis of four penicillins and cephaloridine by R-mediated PCases and cephalosporinase is shown in Table 5 . T-1220, CB-PC, and AB-PC were niae GN6445, and P. aeruginosa NC-5 are shown in Table 6 . Against infection of mice with E. coli MIA707, T-1220 was as active as CB-PC, but less active than AB-PC. Against infections with K. pneumoniae, in vivo effectiveness of T-1220 was much higher than that of CB-PC and AB-PC. T-1220 also showed much higher in vivo effectiveness against P. aeruginosa than did CB-PC.
